BIOTA PHARMACEUTIALS INC's ticker is BOTA and the CUSIP is 090694100. A total of 56 filers reported holding BIOTA PHARMACEUTIALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,101,000 | +97.7% | 734,226 | +155.7% | 0.00% | – |
| Q4 2015 | $557,000 | -99.7% | 287,119 | -94.4% | 0.00% | -100.0% |
| Q3 2015 | $174,340,000 | +31256.1% | 5,102,781 | +1799.8% | 0.01% | – |
| Q2 2015 | $556,000 | -8.4% | 268,594 | +1.8% | 0.00% | – |
| Q1 2015 | $607,000 | +25.7% | 263,928 | +22.3% | 0.00% | – |
| Q4 2014 | $483,000 | -2.0% | 215,876 | +8.1% | 0.00% | – |
| Q3 2014 | $493,000 | -3.9% | 199,781 | +11.0% | 0.00% | – |
| Q2 2014 | $513,000 | -19.5% | 179,977 | +72.7% | 0.00% | – |
| Q1 2014 | $637,000 | +308.3% | 104,220 | +181.1% | 0.00% | – |
| Q4 2013 | $156,000 | -46.2% | 37,075 | -46.4% | 0.00% | – |
| Q3 2013 | $290,000 | +25.0% | 69,234 | +3.2% | 0.00% | – |
| Q2 2013 | $232,000 | – | 67,102 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 1,407,700 | $3,153,000 | 0.92% |
| Broadfin Capital, LLC | 5,223,422 | $11,700,000 | 0.51% |
| Avoro Capital Advisors LLC | 258,586 | $579,000 | 0.39% |
| RA Capital Management | 1,378,770 | $3,088,000 | 0.33% |
| BVF INC/IL | 435,900 | $976,000 | 0.19% |
| Dominick & Dominick LLC | 150,166 | $336,000 | 0.17% |
| TOWERVIEW LLC | 160,000 | $358,000 | 0.16% |
| KNOTT DAVID M | 268,327 | $601,052,000 | 0.14% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 292,807 | $656,000 | 0.09% |
| Baker Brothers Advisors | 1,106,910 | $2,479,000 | 0.02% |